Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
Introduced
Moved
Reached a final decision
Became law
Derived from the official record below.
Officially: “Clinical Research Pharmacies and Clinical Trials - Permits and Ownership” Read the full text
2026 session
What it does
Establishing a clinical research pharmacy permit; authorizing the State Board of Pharmacy to issue a clinical research pharmacy permit; authorizing a health care provider to hold an ownership interest in a clinical research pharmacy under certain circumstances; prohibiting an individual from being required to obtain a license, certification, or authorization to practice under certain provisions of law to own or have an ownership interest in a clinical research pharmacy; etc.
From the official legislative record, shown verbatim. Not legal advice.
Where it is
First reading, house of origin · Feb 5, 2026
Hearing · Mar 3, 2026
Committee report, house of origin: Favorable with Amendments · Mar 18, 2026
Second reading, house of origin: Passed with Amendments · Mar 2, 2026
Third reading, house of origin: Passed · Mar 4, 2026
First reading, opposite house · Mar 8, 2026
Committee report, opposite house: Favorable · Apr 10, 2026
Second reading, opposite house: Passed · Mar 27, 2026
Third reading, opposite house: Passed · Mar 30, 2026
The numbers
1
sponsor on the bill
Sponsors
Every fact on this page links to its source, starting with the official bill record. Last action: Approved by the Governor - Chapter 206 (as of Aug 30, 2026).